South Korean Dental Stock Abutment Market Slows as CAD/CAM Solutions Become Affordable

Share Article

According to a new report by iData Research, the recovering Japanese market, the switch to CAD/CAM in South Korea, and growing national incomes in Australia are all set to push the implant market forward in Asia-Pacific.

“Units of CAD/CAM abutments have been demonstrating high double-digit growth and are increasingly acquiring share from stock and custom cast abutments.”

According to a new report from by iData Research (http://www.idataresearch.com), stock dental abutments still represent a cheaper and faster alternative to CAD/CAM for dental implant procedures in South Korea. However, CAD/CAM technology is expected to become progressively more efficient and cost effective. Thus, stock abutments are expected to continue to lose unit share to CAD/CAM abutments.

“Prices have dramatically decreased, making CAD/CAM solutions more affordable to dental professionals,” explains Dr. Kamran Zamanian, CEO of iData. “Units of CAD/CAM abutments have been demonstrating high double-digit growth and are increasingly acquiring share from stock and custom cast abutments.”

As adoption of CAD/CAM abutments settles, growth within the stock abutment market is expected to recover. Stock abutments continue to represent a significantly cheaper and more immediate solution that is suitable for a wide range of dental implant cases, especially those related to tooth-loss in the posterior regions. However, stock abutments will continue to grow at a slower rate relative to the CAD/CAM sector of the market. As a result, stock abutment units will grow to represent a lower portion of the overall abutment units in South Korea.

Other key findings from the 2015 edition of the iData Research report entitled Asia-Pacific Markets for Dental Implants and Final Abutments:

Technological Improvements
Technological improvements, especially in the case of CAD/CAM technology, are set to drive the South Korean market forward. Customized abutments, specifically CAD/CAM abutments help improve accuracy in the placement of an implant and increase the overall success rate of an implant. For this reason, dental professionals are moving towards CAD/CAM abutments, which are more expensive than their stock abutment counterparts.

Commoditization of Abutments
Premium players in South Korea have been consistently losing market share in the final abutment market, as generic brands offering cheaper imitations have been aggressively entering the market. This has drastically lowered the ASP of abutments, and will continue to result in premium implant players losing market share.

Leading Competitors
Five local Korean dental implant companies dominate the South Korean market for implants, leaving marginal room for globally leading premium implant companies to compete. The remainder of the market is shared by four premium implant leaders and a number of smaller Korean discount companies.

For Further Information
More on the markets for dental implants and final abutments in South Korea can be found in the 2015 edition report from by iData entitled Asia-Pacific Markets for Dental Implants and Final Abutments. This report covers South Korea, Japan, Australia, and China, and includes sub-segments by country, and detailed market and unit share analysis.

The full iData series on the market for dental implants and final abutments also covers the U.S., Mexico, Brazil, Argentina, India, China, Canada, and 15 countries in Europe. Full reports provide a comprehensive analysis including units sold, procedure numbers, market value, forecasts, as well as detailed competitive market shares and analysis of major players’ success strategies in each market and segment.

Register online or email us at info(at)idataresearch(dot)net for an Asia-Pacific Markets for Dental Implants and Final Abutments report brochure and synopsis.

About iData Research
iData Research (http://www.idataresearch.com) is an international market research and consulting group focused on providing market intelligence for medical device and pharmaceutical companies. iData covers research in: Diabetes Drugs, Diabetes Devices, Pharmaceuticals, Anesthesiology, Wound Management, Orthopedics, Cardiovascular, Ophthalmics, Endoscopy, Gynecology, Urology and more.

Share article on socal media or email:

View article via:

Pdf Print

Contact Author

Marvin Cidamon
iData Research
+1 (604) 266-6933 Ext: 205
Email >

Marvin Cidamon
iData Research
604-266-6933 205
Email >
@iDataResearch
Follow >
iData Research
Like >
iData Research

Follow us on
Visit website